Navigation Links
Summit Yields One-of-a-Kind Opportunity To Reduce Prescription Drug Overdoses
Date:11/16/2012

NEWARK, Del., Nov. 16, 2012 /PRNewswire-USNewswire/ --Today, a not-for-profit organization presenting at the Delaware Prescription Drug Abuse Summit appealed to the event's host, Attorney General Beau Biden, for assistance in preventing medication overdoses.  The Center for Lawful Access and Abuse Deterrence (CLAAD) asked Biden to work closely with his father, Vice President Joe Biden, to ensure that federal regulators properly implement Obama-Biden Administration drug policies. 

During CLAAD's presentation at the summit, Director Michael Barnes warned that pain medications without added safety features could flood back into communities in the coming weeks if the Food and Drug Administration (FDA) fails to follow the Obama-Biden strategy.

In recent years, the makers of the opioid pain relievers OxyContin and Opana removed their traditional products from the market in favor of new versions designed to impede certain forms of intentional abuse.  Preliminary, peer-reviewed evidence indicates that dealers and abusers have less interest in the new drugs with abuse-deterrent features.[1]  The new medications cost no more to consumers than their prior formulations. 

Several drug companies have asked the FDA for approval to bring the old, more readily abused formulations of the drugs back to the market as early as January 2013. 

"The Administration's prescription drug abuse prevention plan provides express support for abuse-deterrent medications," Barnes said.

Earlier this month, CLAAD and nine other public health and safety organizations sent a letter to the FDA urging it to implement Obama-Biden policy, foster the transition to abuse-deterrent medications, and prevent the marketing of generic versions of the drugs that do not have similar safety features.

"At today's summit, I asked General Biden to work closely with his father to make certain that the FDA does the right thing," Barnes said. 

Vice President Biden is considered one of the most accomplished national leaders in drug policy, having served as chairman of both the U.S. Senate Judiciary Committee and Drug Caucus.

"I have confidence that the Bidens will ensure that the FDA supports the shift to abuse-deterrent medications," Barnes concluded.  "We reached a turning point in our nation's prescription drug abuse epidemic at today's summit." 

[1] Cicero TJ, Ellis MS, Surratt HL. Effect of abuse-deterrent formulation of OxyContin. New England Journal of Medicine. 2012;367(2):187-189.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit
2. Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai
3. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
4. Daniel Sontupe, SVP, Director of Market Access, at The CementBloc, to Present on Uncovering the Value in a Patient Support Program at CBI Summit
5. GDS Internationals Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
6. Cleveland Clinics 2012 Medical Innovation Summit Highlights Orthopaedic Technologies
7. Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits
8. Online Career Service Holds Third Virtual Job Summit
9. FDAnews announces Third Annual Pharmaceutical Labeling Summit
10. VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings
11. FDAnews announces Fifth Annual Risk Management & Drug Safety Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
(Date:6/24/2016)... Gilbert, Arizona (PRWEB) , ... June 24, 2016 ... ... Gilbert-based practice, is supporting the upcoming 2016 Miss Arizona pageant as its official ... primarily serves Scottsdale, Tempe, Mesa, and Chandler, Arizona. , Dr. Olson says ...
(Date:6/24/2016)... IL (PRWEB) , ... June 24, 2016 , ... ... Beard, DDS, and Randall Markarian, DDS, are co-chairs for the Illinois State Dental ... clinic Friday-Saturday, July 15-16 at the Gateway Convention Center in Collinsville. ...
Breaking Medicine News(10 mins):